Transdermal Drug Delivery Systems Global Market Report 2025
상품코드:1760732
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 175 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
경피 약물 전달 시스템 시장 규모는 향후 몇 년간 강력한 성장세를 보일 것으로 예상됩니다. 2029년까지 연평균 8.0%의 성장률(CAGR)로 550억 달러에 달할 것으로 예측됩니다. 예측 기간 동안의 성장은 비침습적 치료에 대한 환자 선호도 증가, 만성질환 유병률 증가, 편리한 약물 전달 옵션에 대한 수요 증가, 통증 관리에 대한 적용 확대, 새로운 약물 전달 시스템에 대한 규제 당국의 지원 등의 요인에 의해 이루어질 것으로 예측됩니다. 이 기간의 주요 동향으로는 개인 맞춤형 약물 전달의 혁신, 흡수율 향상을 위한 나노기술의 활용, 스마트 패치 개발, 피부 침투 기술의 발전, 생리활성 화합물의 통합, 만성질환 관리를 위한 웨어러블 디바이스의 발전 등을 들 수 있습니다.
만성질환의 유병률 증가는 향후 경피 약물 전달 시스템 시장의 성장을 견인할 것으로 예측됩니다. 당뇨병, 심장병과 같은 만성질환은 지속적인 관리가 필요하고 일상적인 활동을 제한합니다. 앉아있는 생활습관은 체중 증가, 심혈관계 건강 악화, 대사 불균형 등을 유발하여 만성질환 증가에 일조하고 있습니다. 경피약물전달시스템은 이러한 질환에서 피부를 통해 약물을 지속적으로 제어 방출하여 환자의 복약 순응도를 향상시키고 안정적인 치료 수준을 보장하기 위해 사용됩니다. 예를 들어, 2023년 6월, Institute for Health Metrics and Evaluation은 전 세계 5억 명 이상의 사람들이 당뇨병을 앓고 있으며, 이 수치는 2050년까지 두 배로 증가하여 13억 명에 이를 것으로 예상한다고 보고했습니다. 따라서 만성 질환의 유병률 증가는 경피 약물 전달 시스템 시장 확대를 촉진하고 있습니다.
경피 약물 전달 시스템 시장의 주요 기업들은 약물 흡수와 환자 순응도를 향상시키기 위해 마이크로니들 기술과 같은 기술 발전에 집중하고 있습니다. 마이크로니들은 통증 없이 피부를 통해 약물을 전달할 수 있는 최소침습적 장치로, 기존 주사에 대한 최소침습적 대안을 제공합니다. 예를 들어, 2024년 10월 한국의 대웅제약은 마이크로니들 플랫폼 CLOPAM을 발표했습니다. 이 플랫폼은 약물 전달의 효율성을 크게 향상시키고, 주사에 따른 불편함을 최소화하며, 제어되고 지속적인 약물 방출을 실현합니다. 이 플랫폼의 목표는 경구 또는 주사 치료를 대체할 수 있는 통증이 없고 일관된 치료법을 제공하여 환자의 순응도와 치료 효과를 향상시키는 것입니다.
본 보고서는 강력한 성장세를 보이고 있는 경피 약물 전달 시스템 시장에 중점을 두고 있으며, 향후 10년 및 그 이후 시장을 형성할 트렌드에 대한 가이드를 제공합니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 - 금리, 인플레이션, 지정학, 무역 전쟁과 관세, 그리고 코로나재난과 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 경피 약물전달 시스템 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 이용 산업 분석
세계의 경피 약물전달 시스템 시장 : 성장률 분석
세계의 경피 약물전달 시스템 시장 실적 : 규모와 성장, 2019-2024
세계의 경피 약물전달 시스템 시장 예측 : 규모와 성장, 2024-2029, 2034F
세계경피 약물전달 시스템 전체 시장(TAM)
제6장 시장 세분화
세계의 경피 약물전달 시스템 시장 : 처방 유형별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
Drug-In-Patch
Reservoir Type
Matrix Type
Microreservoir Type
세계의 경피 약물전달 시스템 시장 : 기술별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
Iontophoresis
Microoperation
세계의 경피 약물전달 시스템 시장 : 용도별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
통증 관리
중추신경계
심혈관 질환
금연
세계의 경피 약물전달 시스템 시장 : 최종사용자별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
병원
재택 헬스케어
제약회사
연구기관
세계의 경피 약물전달 시스템 시장 : Drug-In-Patch 유형별 세분화, 분석과 예측, 2019-2024, 2024-2029F, 2034F
단층 약제 내접착제
다층 약제 내접착제
세계의 경피 약물전달 시스템 시장 : Reservoir Type별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
겔 리저버 시스템
액체 저장 시스템
고체 저장층 시스템
세계의 경피 약물전달 시스템 시장 : Matrix Type별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
폴리머 매트릭스 시스템
지질 매트릭스 시스템
하이드로겔 매트릭스 시스템
세계의 경피 약물전달 시스템 시장, Microreservoir Type별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
마이크로니들 어레이
마이크로 에멀전 리저버
나노입자 주입 리저버
제7장 지역별/국가별 분석
세계의 경피 약물전달 시스템 시장 : 지역별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
세계의 경피 약물전달 시스템 시장 : 국가별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
경피 약물전달 시스템 시장 : 경쟁 구도
경피 약물전달 시스템 시장 : 기업 개요
Pfizer Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
Johnson & Johnson : 개요, 제품 및 서비스, 전략 및 재무 분석
AbbVie Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
Bayer AG : 개요, 제품 및 서비스, 전략 및 재무 분석
Novartis AG : 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
GSK plc
3M Company
Teva Pharmaceutical Industries Ltd.
Boehringer Ingelheim GmbH
Mylan NV
UCB S.A.
Skyepharma
Noven Pharmaceuticals Inc.
Hisamitsu Pharmaceutical Co. Inc.
Watson Pharmaceuticals Inc.
Endo International plc
Transdermal Technologies Inc.
Grunenthal GmbH
4P Therapeutics LLC
Actavis Inc.
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장 잠재력이 높은 국가, 부문, 전략
경피 약물전달 시스템 시장(2029년) : 새로운 기회를 제공하는 국가
경피 약물전달 시스템 시장(2029년) : 새로운 기회를 제공하는 부문
경피 약물전달 시스템 시장(2029년) : 성장 전략
시장 동향에 근거한 전략
경쟁 전략
제36장 부록
LSH
영문 목차
영문목차
Transdermal drug delivery systems are methods used to administer medication through the skin, allowing for a controlled, continuous release of the drug into the bloodstream over a period of time. These systems are typically in the form of a patch or similar device applied to the skin, which gradually releases the medication, offering benefits such as avoiding the digestive system and ensuring stable drug levels in the body.
The main types of formulations for transdermal drug delivery systems include drug-in-patch, reservoir, matrix, and microreservoir types. The drug-in-patch formulation is especially common in the consumer health market due to its convenience, making it ideal for treatments such as nicotine replacement and hormone therapy. Key technologies used in transdermal drug delivery include iontophoresis and microporation. These systems are applied in various fields, including pain management, central nervous system disorders, cardiovascular diseases, and smoking cessation, and are used in settings such as hospitals, home healthcare, pharmaceutical companies, and research institutions.
The transdermal drug delivery systems market research report is one of a series of new reports from The Business Research Company that provides transdermal drug delivery systems market statistics, including the transdermal drug delivery systems industry global market size, regional shares, competitors with the transdermal drug delivery systems market share, detailed transdermal drug delivery systems market segments, market trends, and opportunities, and any further data you may need to thrive in the transdermal drug delivery systems industry. This transdermal drug delivery systems market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The transdermal drug delivery systems market size has grown strongly in recent years. It will grow from $37.30 billion in 2024 to $40.39 billion in 2025 at a compound annual growth rate (CAGR) of 8.3%. The growth observed in the historical period can be attributed to factors such as an increased demand for non-invasive drug delivery, better patient adherence to treatments, enhanced bioavailability, a rise in chronic disease prevalence, and a growing preference for self-administration.
The transdermal drug delivery systems market size is expected to see strong growth in the next few years. It will grow to $55.00 billion in 2029 at a compound annual growth rate (CAGR) of 8.0%. The projected growth in the forecast period is driven by factors including a greater patient preference for non-invasive treatments, the rising prevalence of chronic diseases, an increasing demand for convenient drug delivery options, expanded uses in pain management, and regulatory support for new drug delivery systems. Key trends during this period include innovations in personalized drug delivery, the use of nanotechnology for improved absorption, the development of smart patches, advancements in skin penetration techniques, the incorporation of bioactive compounds, and breakthroughs in wearable devices for managing chronic conditions.
The increasing prevalence of chronic diseases is expected to drive the growth of the transdermal drug delivery systems market in the future. Chronic diseases, such as diabetes and heart disease, require ongoing management and limit daily activities. Factors such as sedentary lifestyles, which lead to weight gain, poor cardiovascular health, and metabolic imbalances, contribute to the rise in chronic conditions. Transdermal drug delivery systems are used in these diseases to provide a continuous, controlled release of medication through the skin, improving patient adherence and ensuring stable therapeutic levels. For example, in June 2023, the Institute for Health Metrics and Evaluation reported that over half a billion people worldwide were living with diabetes, with this number expected to double, reaching 1.3 billion by 2050. Thus, the growing prevalence of chronic diseases is driving the market expansion for transdermal drug delivery systems.
Key players in the transdermal drug delivery systems market are concentrating on technological advancements such as microneedle technology to improve drug absorption and patient compliance. Microneedles are minimally invasive devices that deliver drugs through the skin painlessly, offering a less invasive alternative to traditional injections. For example, in October 2024, Daewoong Pharmaceutical Co. Ltd., a South Korea-based company, launched its microneedle platform CLOPAM. This platform significantly enhances drug delivery efficiency, minimizes the discomfort associated with injections, and provides controlled, sustained medication release. The goal is to offer a painless and consistent alternative to oral or injectable treatments, thereby improving patient compliance and treatment effectiveness.
In August 2022, LTS Lohmann Therapie-Systeme AG, a pharmaceutical company based in Germany, acquired Tapemark Inc. for an undisclosed amount. This acquisition strengthens LTS's drug delivery capabilities, expanding its expertise in production and bolstering its position in the field of transdermal and advanced drug delivery solutions. Tapemark Inc., based in the US, specializes in the manufacturing of transdermal drug delivery systems.
Major players in the transdermal drug delivery systems market are Pfizer Inc., Johnson & Johnson, AbbVie Inc., Bayer AG, Novartis AG, GSK plc, 3M Company, Teva Pharmaceutical Industries Ltd., Boehringer Ingelheim GmbH, Mylan NV, UCB S.A., Skyepharma, Noven Pharmaceuticals Inc., Hisamitsu Pharmaceutical Co. Inc., Watson Pharmaceuticals Inc., Endo International plc, Transdermal Technologies, Inc., Grunenthal GmbH, 4P Therapeutics LLC, and Actavis Inc.
North America was the largest region in the transdermal drug delivery systems market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in transdermal drug delivery systems report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the transdermal drug delivery systems market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The transdermal drug delivery systems market consists of sales of gels, creams, and microneedles. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values generated by organizations in the defined geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Transdermal Drug Delivery Systems Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on transdermal drug delivery systems market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for transdermal drug delivery systems ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The transdermal drug delivery systems market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Formulation Type: Drug-In-Patch; Reservoir Type; Matrix Type; Microreservoir Type
2) By Technology: Iontophoresis; Microporation
3) By Application: Pain Management; Central Nervous System; Cardiovascular Diseases; Smoking Cessation
4) By End User: Hospitals; Home Healthcare; Pharmaceutical Companies; Research Institutes
Subsegments:
1) By Drug-In-Patch: Single-layer Drug-in-Adhesive; Multi-layer Drug-in-Adhesive
2) By Reservoir Type: Gel Reservoir Systems; Liquid Reservoir Systems; Solid Reservoir Systems
3) By Matrix Type: Polymer Matrix Systems; Lipid Matrix Systems; Hydrogel Matrix Systems
4) By Microreservoir Type: Microneedle Arrays; Microemulsion Reservoirs; Nanoparticle-Infused Reservoirs
Companies Mentioned: Pfizer Inc.; Johnson & Johnson; AbbVie Inc.; Bayer AG; Novartis AG
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Transdermal Drug Delivery Systems Market Characteristics
3. Transdermal Drug Delivery Systems Market Trends And Strategies
4. Transdermal Drug Delivery Systems Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
5. Global Transdermal Drug Delivery Systems Growth Analysis And Strategic Analysis Framework
5.1. Global Transdermal Drug Delivery Systems PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Transdermal Drug Delivery Systems Market Growth Rate Analysis
5.4. Global Transdermal Drug Delivery Systems Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Transdermal Drug Delivery Systems Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Transdermal Drug Delivery Systems Total Addressable Market (TAM)
6. Transdermal Drug Delivery Systems Market Segmentation
6.1. Global Transdermal Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Drug-In-Patch
Reservoir Type
Matrix Type
Microreservoir Type
6.2. Global Transdermal Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Iontophoresis
Microoperation
6.3. Global Transdermal Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Pain Management
Central Nervous System
Cardiovascular Diseases
Smoking Cessation
6.4. Global Transdermal Drug Delivery Systems Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Home Healthcare
Pharmaceutical Companies
Research Institutes
6.5. Global Transdermal Drug Delivery Systems Market, Sub-Segmentation Of Drug-In-Patch, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Single-layer Drug-in-Adhesive
Multi-layer Drug-in-Adhesive
6.6. Global Transdermal Drug Delivery Systems Market, Sub-Segmentation Of Reservoir Type, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Gel Reservoir Systems
Liquid Reservoir Systems
Solid Reservoir Systems
6.7. Global Transdermal Drug Delivery Systems Market, Sub-Segmentation Of Matrix Type, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Polymer Matrix Systems
Lipid Matrix Systems
Hydrogel Matrix Systems
6.8. Global Transdermal Drug Delivery Systems Market, Sub-Segmentation Of Microreservoir Type, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Microneedle Arrays
Microemulsion Reservoirs
Nanoparticle-Infused Reservoirs
7. Transdermal Drug Delivery Systems Market Regional And Country Analysis
7.1. Global Transdermal Drug Delivery Systems Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Transdermal Drug Delivery Systems Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Transdermal Drug Delivery Systems Market
8.1. Asia-Pacific Transdermal Drug Delivery Systems Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Transdermal Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Transdermal Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Transdermal Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Transdermal Drug Delivery Systems Market
9.1. China Transdermal Drug Delivery Systems Market Overview
9.2. China Transdermal Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Transdermal Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Transdermal Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Transdermal Drug Delivery Systems Market
10.1. India Transdermal Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Transdermal Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Transdermal Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Transdermal Drug Delivery Systems Market
11.1. Japan Transdermal Drug Delivery Systems Market Overview
11.2. Japan Transdermal Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Transdermal Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Transdermal Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Transdermal Drug Delivery Systems Market
12.1. Australia Transdermal Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Transdermal Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Transdermal Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Transdermal Drug Delivery Systems Market
13.1. Indonesia Transdermal Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Transdermal Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Transdermal Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Transdermal Drug Delivery Systems Market
14.1. South Korea Transdermal Drug Delivery Systems Market Overview
14.2. South Korea Transdermal Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Transdermal Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Transdermal Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Transdermal Drug Delivery Systems Market
15.1. Western Europe Transdermal Drug Delivery Systems Market Overview
15.2. Western Europe Transdermal Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Transdermal Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Transdermal Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Transdermal Drug Delivery Systems Market
16.1. UK Transdermal Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Transdermal Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Transdermal Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Transdermal Drug Delivery Systems Market
17.1. Germany Transdermal Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Transdermal Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Transdermal Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Transdermal Drug Delivery Systems Market
18.1. France Transdermal Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Transdermal Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Transdermal Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Transdermal Drug Delivery Systems Market
19.1. Italy Transdermal Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Transdermal Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Transdermal Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Transdermal Drug Delivery Systems Market
20.1. Spain Transdermal Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Transdermal Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Transdermal Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Transdermal Drug Delivery Systems Market
21.1. Eastern Europe Transdermal Drug Delivery Systems Market Overview
21.2. Eastern Europe Transdermal Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Transdermal Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Transdermal Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Transdermal Drug Delivery Systems Market
22.1. Russia Transdermal Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Transdermal Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Transdermal Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Transdermal Drug Delivery Systems Market
23.1. North America Transdermal Drug Delivery Systems Market Overview
23.2. North America Transdermal Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Transdermal Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Transdermal Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Transdermal Drug Delivery Systems Market
24.1. USA Transdermal Drug Delivery Systems Market Overview
24.2. USA Transdermal Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Transdermal Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Transdermal Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Transdermal Drug Delivery Systems Market
25.1. Canada Transdermal Drug Delivery Systems Market Overview
25.2. Canada Transdermal Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Transdermal Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Transdermal Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Transdermal Drug Delivery Systems Market
26.1. South America Transdermal Drug Delivery Systems Market Overview
26.2. South America Transdermal Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Transdermal Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Transdermal Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Transdermal Drug Delivery Systems Market
27.1. Brazil Transdermal Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Transdermal Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Transdermal Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Transdermal Drug Delivery Systems Market
28.1. Middle East Transdermal Drug Delivery Systems Market Overview
28.2. Middle East Transdermal Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Transdermal Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Transdermal Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Transdermal Drug Delivery Systems Market
29.1. Africa Transdermal Drug Delivery Systems Market Overview
29.2. Africa Transdermal Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Transdermal Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Transdermal Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Transdermal Drug Delivery Systems Market Competitive Landscape And Company Profiles
30.1. Transdermal Drug Delivery Systems Market Competitive Landscape
30.2. Transdermal Drug Delivery Systems Market Company Profiles
30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
30.2.3. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.4. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
30.2.5. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
31. Transdermal Drug Delivery Systems Market Other Major And Innovative Companies
31.1. GSK plc
31.2. 3M Company
31.3. Teva Pharmaceutical Industries Ltd.
31.4. Boehringer Ingelheim GmbH
31.5. Mylan NV
31.6. UCB S.A.
31.7. Skyepharma
31.8. Noven Pharmaceuticals Inc.
31.9. Hisamitsu Pharmaceutical Co. Inc.
31.10. Watson Pharmaceuticals Inc.
31.11. Endo International plc
31.12. Transdermal Technologies Inc.
31.13. Grunenthal GmbH
31.14. 4P Therapeutics LLC
31.15. Actavis Inc.
32. Global Transdermal Drug Delivery Systems Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Transdermal Drug Delivery Systems Market
34. Recent Developments In The Transdermal Drug Delivery Systems Market
35. Transdermal Drug Delivery Systems Market High Potential Countries, Segments and Strategies
35.1 Transdermal Drug Delivery Systems Market In 2029 - Countries Offering Most New Opportunities
35.2 Transdermal Drug Delivery Systems Market In 2029 - Segments Offering Most New Opportunities
35.3 Transdermal Drug Delivery Systems Market In 2029 - Growth Strategies
